Results 181 to 190 of about 214,856 (315)
Management of a large limbal dermoid with excision and ipsilateral limbal epithelial translocation. [PDF]
Chaurasia S, Ramappa M.
europepmc +1 more source
Abstract Background Oral non‐steroidal anti‐inflammatory drugs (NSAIDs) are commonly used for analgesia in dogs with spontaneous chronic corneal epithelial defects (SCCEDs). Topical NSAIDs can delay epithelialisation and promote stromal melting, but the safety of systemic NSAIDs in SCCEDs is unknown.
Kaitlyn Scheunemann +2 more
wiley +1 more source
Limbal stem cell deficiency secondary to topical glaucoma medication: a scoping review. [PDF]
Liu AWY, Wan Abdul Halim WH, Md Din N.
europepmc +1 more source
The structure and transparency of the cornea
D. Maurice
semanticscholar +1 more source
ABSTRACT Background Sinonasal malignancies with orbital involvement may be managed with orbit‐sacrificing or orbit‐preserving surgical approaches, with a recent shift towards orbital preservation to reduce postoperative morbidity while maintaining oncological success.
Claire Jing‐Wen Tan +9 more
wiley +1 more source
The Future of Interventional Keratoconus Management: Perspectives on Integrating Epithelium-on Oxygen-Enriched Cross-Linking into Comprehensive Care Pathways. [PDF]
Beckman KA, Syed ZA, Gromacki SJ.
europepmc +1 more source
Abstract Objective Medical devices are reviewed by the US Food and Drug Administration (FDA) for safety and effectiveness. Class II devices can receive 510(k) clearance if they are “substantially equivalent” to an existing predicate device. This process can be repeated iteratively, leading to a lineage of predicates for newly cleared devices.
Yiting Lin +3 more
wiley +1 more source
Residual refraction after myopic implantable collamer lens implantation: clinical data vs optical models. [PDF]
Oleszko A +2 more
europepmc +1 more source
Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series
ABSTRACT We present three patients who developed allergic contact dermatitis (ACD) from benzalkonium chloride (BAK) in ophthalmic drops. BAK is a preservative commonly found in ophthalmic formulations and there is a rising trend of ACD to this allergen. The irritant and sensitising properties of BAK on the ocular mucosa will be discussed.
Arav Kannen +2 more
wiley +1 more source
Les Tertúlies Terminològiques de RITerm: un espai de debat sobre terminologia
Ioana Cornea
doaj

